These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 19900603)
1. [Bioanalytics in medicinal chemistry: from assay development to evolutive drug design]. Jose J Ann Pharm Fr; 2009 Nov; 67(6):399-407. PubMed ID: 19900603 [TBL] [Abstract][Full Text] [Related]
3. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations. Srinivas NR Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470 [TBL] [Abstract][Full Text] [Related]
4. Alternative strategies in drug development: clinical pharmacological aspects. Kuhlmann J Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949 [TBL] [Abstract][Full Text] [Related]
5. From targets to leads: the importance of advanced data analysis for decision support in drug discovery. Fischer HP; Heyse S Curr Opin Drug Discov Devel; 2005 May; 8(3):334-46. PubMed ID: 15892249 [TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
7. Application of statistical 'design of experiments' methods in drug discovery. Tye H Drug Discov Today; 2004 Jun; 9(11):485-91. PubMed ID: 15149624 [TBL] [Abstract][Full Text] [Related]
8. Importance of molecular computer modeling in anticancer drug development. Geromichalos GD J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268 [TBL] [Abstract][Full Text] [Related]
9. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers. Lee JW; Figeys D; Vasilescu J Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683 [TBL] [Abstract][Full Text] [Related]
10. Affinity-based screening techniques for enhancing lead discovery. Comess KM; Schurdak ME Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950 [TBL] [Abstract][Full Text] [Related]
11. Application of combinatorial library methods in cancer research and drug discovery. Lam KS Anticancer Drug Des; 1997 Apr; 12(3):145-67. PubMed ID: 9154108 [TBL] [Abstract][Full Text] [Related]
13. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery. Fischer HP Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773 [TBL] [Abstract][Full Text] [Related]
14. The 7 TM G-protein-coupled receptor target family. Jacoby E; Bouhelal R; Gerspacher M; Seuwen K ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930 [TBL] [Abstract][Full Text] [Related]
15. Promises of biomarkers in drug development--a reality check. Marrer E; Dieterle F Chem Biol Drug Des; 2007 Jun; 69(6):381-94. PubMed ID: 17581232 [TBL] [Abstract][Full Text] [Related]
16. Timely synthetic support for medicinal chemists. Potoski J Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160 [TBL] [Abstract][Full Text] [Related]
17. Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective. Zhao H Drug Discov Today; 2007 Feb; 12(3-4):149-55. PubMed ID: 17275735 [TBL] [Abstract][Full Text] [Related]
18. A review of high throughput technology for the screening of natural products. Mishra KP; Ganju L; Sairam M; Banerjee PK; Sawhney RC Biomed Pharmacother; 2008 Feb; 62(2):94-8. PubMed ID: 17692498 [TBL] [Abstract][Full Text] [Related]
19. Drug research: from the idea to the product. Kuhlmann J Int J Clin Pharmacol Ther; 1997 Dec; 35(12):541-52. PubMed ID: 9455711 [TBL] [Abstract][Full Text] [Related]
20. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]